© 2017 The Author(s). Background: Eicosapentaenoic acid (EPA, C20:5n-3), docosahexaenoic acid (DHA, C22:6n-3) and arachidonic acid (AA, C20:4n-6) are long-chain polyunsaturated fatty acids (LCPUFAs) with relevant roles in the organism. EPA and DHA are synthesized from the precursor alpha-linolenic acid (ALA, C18:3n-3), whereas AA is produced from linoleic acid (LA, C18:2n-6) through the action of Δ5 and Δ6-desaturases. High-fat diet (HFD) decreases the activity of both desaturases and LCPUFA accretion in liver and other tissues. Hydroxytyrosol (HT), a natural antioxidant, has an important cytoprotective effects in different cells and tissues. Methods: Male mice C57BL/6 J were fed a control diet (CD) (10% fat, 20% protein, 70% carbohydrates)...
This is the publisher’s final pdf. The published article is copyrighted by the American Society for ...
BACKGROUND: There are only few data relating the metabolic consequences of feeding diets very low in...
Liver-specific ablation of cytochrome P450 reductase in mice (LCN) results in hepatic steatosis that...
Background: Eicosapentaenoic acid (EPA, C20:5n-3), docosahexaenoic acid (DHA, C22:6n-3) and arachido...
Abstract Background Eicosapentaenoic acid (EPA, C20:5n-3), docosahexaenoic acid (DHA, C22:6n-3) and ...
© 2017 The Royal Society of Chemistry.Scope: Non-alcoholic fatty liver disease (NAFLD) is a conditio...
© 2018 The Authors Background: White adipose tissue (WAT) have a relevant metabolic and inflammatory...
Pharmacological therapy for nonalcoholic fatty liver disease (NAFLD) is not approved at the present ...
Pharmacological therapy for nonalcoholic fatty liver disease (NAFLD) is not approved at the present ...
© 2018 Elsevier Inc. High-fat diet (HFD)-fed mice show obesity with development of liver steatosis a...
Artículo de publicación ISIalpha-Linolenic (ALA) and linoleic (LA) acids are precursors of long chai...
Background & Aims: Non-alcoholic fatty liver disease accompanies obesity and is independently associ...
Background & Aims: Non-alcoholic fatty liver disease accompanies obesity and is independently associ...
Objective: The aim of this study was to assess the effect of dietary supplementation with extra virg...
Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease and a ...
This is the publisher’s final pdf. The published article is copyrighted by the American Society for ...
BACKGROUND: There are only few data relating the metabolic consequences of feeding diets very low in...
Liver-specific ablation of cytochrome P450 reductase in mice (LCN) results in hepatic steatosis that...
Background: Eicosapentaenoic acid (EPA, C20:5n-3), docosahexaenoic acid (DHA, C22:6n-3) and arachido...
Abstract Background Eicosapentaenoic acid (EPA, C20:5n-3), docosahexaenoic acid (DHA, C22:6n-3) and ...
© 2017 The Royal Society of Chemistry.Scope: Non-alcoholic fatty liver disease (NAFLD) is a conditio...
© 2018 The Authors Background: White adipose tissue (WAT) have a relevant metabolic and inflammatory...
Pharmacological therapy for nonalcoholic fatty liver disease (NAFLD) is not approved at the present ...
Pharmacological therapy for nonalcoholic fatty liver disease (NAFLD) is not approved at the present ...
© 2018 Elsevier Inc. High-fat diet (HFD)-fed mice show obesity with development of liver steatosis a...
Artículo de publicación ISIalpha-Linolenic (ALA) and linoleic (LA) acids are precursors of long chai...
Background & Aims: Non-alcoholic fatty liver disease accompanies obesity and is independently associ...
Background & Aims: Non-alcoholic fatty liver disease accompanies obesity and is independently associ...
Objective: The aim of this study was to assess the effect of dietary supplementation with extra virg...
Nonalcoholic steatohepatitis (NASH) is a progressive form of nonalcoholic fatty liver disease and a ...
This is the publisher’s final pdf. The published article is copyrighted by the American Society for ...
BACKGROUND: There are only few data relating the metabolic consequences of feeding diets very low in...
Liver-specific ablation of cytochrome P450 reductase in mice (LCN) results in hepatic steatosis that...